Gene · 10498
Papers2,160
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,160
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CARM1 drives sepsis-induced lung injury by coupling PKM2-governed metabolic rewiring to macrophage ferroptosis. | Int Immunopharmacol | 2026 | 42119233 | PubTator, text mining | PubMed |
| Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymoma. | Neuro Oncol | 2026 | 42080900 | PubTator, text mining | PubMed |
| Tailoring PRMT Inhibition: Shifting PRMT7 Selectivity to PRMT4 through "T-Shape" Strategy and "Linker-Specific" Preferences. | J Med Chem | 2026 | 42066234 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities. | J Biomed Sci | 2026 | 41928257 | PubTator, text mining | PubMed |
| CircIQGAP1-CARM1 axis promotes renal cell carcinoma progression through glycolytic reprogramming. | Cell Death Dis | 2026 | 41896523 | PubTator, text mining | PubMed |
| Computational insights into conformational dynamics and allosteric regulation in protein arginine methyltransferase 4 (PRMT4). | Int J Biol Macromol | 2026 | 41895482 | PubTator, text mining | PubMed |
| USP20, a Super-enhancer Regulated Gene, Promotes Acute Myeloid Leukemia Progression through CTNNB1 Deubiquitination. | Int J Biol Sci | 2026 | 41800264 | PubTator, text mining | PubMed |
| A suite of macrocyclic peptide inhibitors and substrate probes for arginine methyltransferases. | Chem Sci | 2026 | 41789358 | PubTator, text mining | PubMed |
| KDM4A Erases the H3R17me2a Mark, Facilitating Chromosome Condensation. | Adv Sci (Weinh) | 2026 | 41747073 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases in protozoan parasites: a new path for antiparasitic chemotherapy? | Microb Cell | 2026 | 41732681 | PubTator, text mining | PubMed |
| Chemomechanical remodeling of glucocorticoid-sensitive fibroblasts for multimodal synergistic therapy of skin fibrosis. | Cell Rep Med | 2026 | 41707648 | PubTator, text mining | PubMed |
| STAT1 signaling controls cholesterol metabolism in epithelial cells and RSV-induced syncytia formation. | Npj Viruses | 2026 | 41699197 | PubTator, text mining | PubMed |
| Tumor cell cycle regulation: integrated perspective of stage characteristics, regulatory networks, and signaling pathway intervention strategies. | Mol Biomed | 2026 | 41692895 | PubTator, text mining | PubMed |
| A radiotherapeutic paradox: ellagic acid sensitizes tumors while attenuating radiation-induced myocardial injury. | Front Oncol | 2026 | 41684598 | PubTator, text mining | PubMed |
| A robust RNAi nanoplatform for precise activation of cGAS-STING pathway and effective immune checkpoint blockade to potentiate cancer immunotherapy. | J Control Release | 2026 | 41655906 | PubTator, text mining | PubMed |
| Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment. | Elife | 2026 | 41632514 | PubTator, text mining | PubMed |
| Reversible arginine methylation regulates mitochondrial IDH2 activity: coordinated control by CARM1 and KDM3A/4A. | Cell Death Dis | 2026 | 41629283 | PubTator, text mining | PubMed |
| Targeting c-Myc-p300-CARM1 complex induces ferroptosis and reduces CD8+ T cell exhaustion in esophageal squamous cell carcinoma. | Int J Biol Sci | 2026 | 41608642 | PubTator, text mining | PubMed |
| Epigenetic and post-translational regulatory networks of ferroptosis in the tumor immune microenvironment. | Exp Hematol Oncol | 2026 | 41588554 | PubTator, text mining | PubMed |
| Therapeutic horizons in the development of PROTAC-based EZH2 inhibitors: recent achievements, comparative analysis, and future perspectives. | RSC Adv | 2026 | 41541203 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10498/papers?page=2